fashion -WSS

fashion

author：focus 2025-10-01 04:10:06 - browse：5262

A woman walks in San Francisco, with her father who has Alzheimer's – public health and science coverage from STAT — Ben Margot/AP

A host of hurdles are slowing the adoption of the new Alzheimer’s drug Leqembi, experts involved in the treatment of patients said Wednesday, from complicated logistics to the fact that many people don’t recognize that their memory loss is a disease soon enough.

Some patients still grapple with whether they want to be diagnosed, even though a treatment exists, the experts said, speaking during a STAT virtual event.

“Even the word for dementia does not always exist in every culture and in every language,” said Hollis Day, chief of geriatrics at Boston Medical Center and a professor at Boston University’s medical school. “And so just getting people to accept that memory loss is not normal aging necessarily, is a big barrier to getting people into diagnosis early enough to benefit from these treatments.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Does aspartame cause cancer? What new WHO guidance says

knowledge

WSS

Congress likely to miss an opportunity to fix drug shortages issue

Involuntary treatment for addiction doesn't work

This gene therapy has record $4.25 million price. It's saved children.

Mike Pence clashes with Tucker Carlson in Iowa

Care demand spikes challenge UnitedHealth’s provider arm

Does aspartame cause cancer? What new WHO guidance says

hotspot

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

focus

Medical records are filled with copy

Special counsel informs Trump he is target in probe of efforts to overturn 2020 election

Psychedelics group wrestles with new pharma identity

6 surprising facts about sugar

ChatGPT in medicine: STAT answers readers' burning questions

Georgia court denies Trump's request to quash DA's 2020 election probe

New air purifier tech could be key to improving indoor air quality

Elon Musk says Twitter has 'negative cash flow' and 'heavy debt'

After affirmative action ruling, medical educators look to 'holistic review'

J&J expands global access to TB drug amid advocacy campaign

Wikipedia

Biotech investment managers search for lucrative opportunities

Asbestos ban is immediate, but health effects will linger for decades

Cancer, immunology, HIV research ensnared in fetal tissue politics

RFK Jr. accused of antisemitic claims about COVID but insists he was misunderstood

Steward Health Care expansion into Malta flopped

American woman kidnapped in Mexico freed after 8 months in captivity: FBI

knowledge

leisure time

explore

Wikipedia